Indications |
Intramuscular Prepubertal cryptorchidism in males Adult: 500-4000 u injected 3 times wkly. Treatment should continue for 1-2 mth after testicular descent. Child: Intramuscular Male infertility due to hypogonadotrophic hypogonadism Adult: 500-4000 u injected 2-3 times wkly. Child: Intramuscular Anovulatory infertility Adult: Single dose of 5000-10,000 u. Up to 3 repeated injections of up to 5000 u each may be given within the following 9 days to prevent corpus luteum insufficiency. Intramuscular Delayed puberty associated with hypogonadism in males Adult: Male: Initially, 500-1500 u twice a wk titrated against plasma-testosterone concentration. |
Contraindications |
Hypersensitivity; precocious puberty, prostatic carcinoma or other androgenic dependent neoplasm. Pregnancy and lactation. |
Warnings / Precautions |
Discontinue therapy if signs of precocious puberty are seen in patients treated for cryptorchidism. Patients with cardiac or renal disease, epilepsy, migraine or asthma. |
Adverse Reactions |
Headache, irritability, restlessness, depression, fatigue, oedema; precocious puberty, gynaecomastia; pain at Inj site; enlargement of preexisting ovarian cysts and possible rupture; arterial thromboembolism; shock; abdominal pain. Potentially Fatal: Ovarian hyperstimulation syndrome (OHSS). |
Mechanism of Actions |
Chorionic Gonadotrophin is a polypeptide hormone produced by the human placenta. It stimulates the production of gonadal steroid hormones by inducing interstitial cells (Leydig cells) of the testis to produce androgens and the corpus luteum of the ovary to produce progesterone. Absorption: Peak concentrations after 6 hrs (IM). Distribution: Mainly in the gonads. Excretion: Via the urine (10-12% of IM dose within 24 hrs). Elimination half-life: 6-11 hrs (initial phase), 23-38 hrs (terminal phase). |
ATC Classification |
G03GA01 - chorionic gonadotrophin ; Belongs to the class of gonadotropins. Used as ovulation stimulants. |
Available As |
|
Human Chorionic Gonadotrophin
Post Review about Human Chorionic Gonadotrophin Click here to cancel reply.
Human Chorionic Gonadotrophin Containing Brands
Human Chorionic Gonadotrophin is used in following diseases
Drug - Drug Interactions of Human Chorionic Gonadotrophin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.